Rasagiline Tartrate

CHEMBL6067988 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

492.6 g/mol

LogP

—

Phase

4

A tartrate salt form of rasagiline with the same therapeutic properties. A MAO-B inhibitor used to treat Parkinson's disease, either alone in early stages or combined with levodopa in more advanced disease, by increasing dopamine levels in the brain.

Moleküler Ağırlık

492,6000 g/mol

TPSA

139,00 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

C#CCN[C@@H]1CCc2ccccc21.C#CCN[C@@H]1CCc2ccccc21.O=C(O)[C@H](O)[C@@H](O)C(=O)O

InChI

InChI=1S/2C12H13N.C4H6O6/c2*1-2-9-13-12-8-7-10-5-3-4-6-11(10)12;5-1(3(7)8)2(6)4(9)10/h2*1,3-6,12-13H,7-9H2;1-2,5-6H,(H,7,8)(H,9,10)/t2*12-;1-,2-/m111/s1

Molecular Formula

C28H32N2O6

HBD / HBA

6 / 8

Döndürülebilir Bağlar

7

Ağır Atomlar

36

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A tartrate salt form of rasagiline with the same therapeutic properties. A MAO-B inhibitor used to treat Parkinson's disease, either alone in early stages or combined with levodopa in more advanced disease, by increasing dopamine levels in the brain.

Yes, Rasagiline Tartrate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL6067988. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 71550735. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Rasagiline Tartrate PillFYI'da

Yapı

Hızlı Veriler

Formül: C28H32N2O6

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.